These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27506252)

  • 1. Transferability study of CHO cell clustering assays for monitoring of pertussis toxin activity in acellular pertussis vaccines.
    Isbrucker R; Daas A; Wagner L; Costanzo A
    Pharmeur Bio Sci Notes; 2016; 2015():97-114. PubMed ID: 27506252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In search of acceptable alternatives to the murine histamine sensitisation test (HIST): what is possible and practical?
    Wagner L; Isbrucker R; Locht C; Arciniega J; Costanzo A; McFarland R; Oh H; Hoonakker M; Descamps J; Andersen SR; Gupta RK; Markey K; Chapsal JM; Lidster K; Casey W; Allen D
    Pharmeur Bio Sci Notes; 2016; 2016():151-170. PubMed ID: 28279256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay.
    Markey K; Douglas-Bardsley A; Hockley J; Le Tallec D; Costanzo A
    Pharmeur Bio Sci Notes; 2018; 2018():112-123. PubMed ID: 30272557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement.
    Arciniega J; Wagner L; Prymula R; Sebo P; Isbrucker R; Descampe B; Chapsal JM; Costanzo A; Hendriksen C; Hoonaker M; Nelson S; Lidster K; Casey W; Allen D
    Pharmeur Bio Sci Notes; 2016; 2015():82-96. PubMed ID: 27506225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test.
    Hoonakker ME; Verhagen LM; van der Maas L; Sloots A; Hendriksen CFM
    Vaccine; 2017 Feb; 35(8):1152-1160. PubMed ID: 28129894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Wagner LD; Corvette LJ; Ngundi MM; Burns DL
    Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of Pertussis toxin BRP batch 2 for CHO clustering assay.
    Wall M; Costanzo A; Le Tallec D; Isbrucker R
    Pharmeur Bio Sci Notes; 2021; 2021():69-87. PubMed ID: 33934749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative study for the calibration of the replacement International Standard for pertussis toxin for use in histamine sensitisation and CHO cell clustering assays.
    Douglas-Bardsley A; Asokanathan C; Tierney S; Hockley J; Markey K
    Biologicals; 2019 Nov; 62():85-92. PubMed ID: 31526657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives.
    Hoonakker M; Arciniega J; Hendriksen C
    Hum Vaccin Immunother; 2017 Nov; 13(11):2522-2530. PubMed ID: 28857652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines.
    Jensen SE; Engelhart Illigen KE; Hasløv KR
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration.
    Xing D; Das RG; Newland P; Corbel M
    Vaccine; 2002 Oct; 20(29-30):3535-42. PubMed ID: 12297399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalidation of the cAMP-PTx reporter assay for quantitative assessment of pertussis toxin activity.
    de Brouwer L; David D; Espitia Ballestas M; Sloots A; Hoonakker ME
    Vaccine; 2022 Jul; 40(32):4513-4521. PubMed ID: 35717266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterisation of a candidate hyper-immune serum for the replacement of the Bordetella pertussis mouse antiserum Biological Reference Preparation.
    Morgeaux S; Bornstein N; Mourton-Gilles C; Chagnaud P; Charbonneau J; Maurin J; Daas A; Variot P; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2020; 2020():141-160. PubMed ID: 32788037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.
    von Hunolstein C; Gomez Miguel MJ; Pezzella C; Scopetti F; Behr-Gross ME; Halder M; Hoffmann S; Levels L; van der Gun J; Hendriksen C
    Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative study on a Guinea pig serological method for the assay of acellular pertussis vaccines.
    Winsnes R; Sesardic D; Daas A; Terao E; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):27-40. PubMed ID: 20144450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of residual pertussis toxin in vaccines using a modified ribosylation assay.
    Yuen CT; Canthaboo C; Menzies JA; Cyr T; Whitehouse LW; Jones C; Corbel MJ; Xing D
    Vaccine; 2002 Nov; 21(1-2):44-52. PubMed ID: 12443661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quantitative analysis of the mechanism involved in pertussis toxin-mediated cell clustering and its implications in the in vitro quality control of diphtheria tetanus and whole cell pertussis vaccines.
    Zamith HPDS; Godinho RO; da Costa Junior VL; Corrado AP
    Toxicol In Vitro; 2021 Feb; 70():105029. PubMed ID: 33059000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nearest neighbor nuclei method to objectify analysis of pertussis toxin-induced clustering.
    Hoonakker ME; Remarque E; Veth J; Sloots A; Bajramovic JJ
    ALTEX; 2022; 39(1):140-148. PubMed ID: 34654933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.